149 related articles for article (PubMed ID: 7940762)
1. Clinical immunosuppressive matrix in organ transplantation.
Land W
Transplant Proc; 1994 Oct; 26(5):2479-84. PubMed ID: 7940762
[No Abstract] [Full Text] [Related]
2. Cyclosporine improves results in HLA-identical sibling renal transplants.
Van Buren D; MacDonell R; Johnson HK; Richie R; Ynares C; Helderman JH; Green W; Crowe D
Transplant Proc; 1994 Oct; 26(5):2514-5. PubMed ID: 7940772
[No Abstract] [Full Text] [Related]
3. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
[No Abstract] [Full Text] [Related]
4. Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
Oppenheimer F; Cofán F; Flores R; Pais B; Ochs J; Ricart MJ; Vilardell J; Campistol JM; Torregrosa JV
Transplant Proc; 1994 Oct; 26(5):2516-7. PubMed ID: 7940773
[No Abstract] [Full Text] [Related]
5. Impact of cyclosporine in the development of immunosuppressive therapy.
Chaverri C
Transplant Proc; 2004 Mar; 36(2 Suppl):80S-82S. PubMed ID: 15041312
[TBL] [Abstract][Full Text] [Related]
6. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients.
Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG
Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805
[No Abstract] [Full Text] [Related]
7. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
Pallardó LM; Sánchez J; Puig N; Sánchez P; Beneyto I; Crespo J; Ros F; Rochera A
Transplant Proc; 1995 Aug; 27(4):2215-6. PubMed ID: 7652778
[No Abstract] [Full Text] [Related]
8. Rational clinical regimens for kidney transplant immunosuppression.
Belitsky P
Transplant Proc; 1994 Oct; 26(5):2485-9. PubMed ID: 7940763
[No Abstract] [Full Text] [Related]
9. Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
Morales JM; Muñoz MA; Campo C; Andres A; Araque A; Alamo C; Praga M; Ortuño T; Hernandez E; Rodicio JL
Transplant Proc; 1994 Oct; 26(5):2511-2. PubMed ID: 7940770
[No Abstract] [Full Text] [Related]
10. [Immunosuppression after organ transplantation].
Wagner K; Erhard J
Zentralbl Chir; 1992; 117(12):648-52. PubMed ID: 1285470
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
Cowan PA; Heizer KE
Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
[TBL] [Abstract][Full Text] [Related]
12. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
[No Abstract] [Full Text] [Related]
13. Does suboptimal immunosuppression contribute to chronic rejection?
Simić S; Djukanović L; Stojković D; Balgojević R; Sinthoić M; Lezaić V; Radivojević D
Transplant Proc; 1995 Feb; 27(1):909-10. PubMed ID: 7879226
[No Abstract] [Full Text] [Related]
14. Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats.
Yagyu K; Takeshita M; Otsuka T; Kubota H; Furuse A; van Breda Vriesman PJ
Transplant Proc; 1994 Aug; 26(4):2343-4. PubMed ID: 8066768
[No Abstract] [Full Text] [Related]
15. Analysis of the risk factors of late failure in renal transplantation under cyclosporine immunosuppression.
Pallardó LM; Sánchez P; Sánchez J; García J; Beneyto I; Orero E; Rochera A
Transplant Proc; 1994 Oct; 26(5):2536-7. PubMed ID: 7940781
[No Abstract] [Full Text] [Related]
16. Cyclosporine-based immunosuppressive strategies for kidney recipients: interim analysis of German data from the Multinational Observational Study (MOST).
Kliem V; Fritsche L; Haller H; Suwelack B; Abendroth D; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U; Ulbricht B;
Transplant Proc; 2005 Apr; 37(3):1597-600. PubMed ID: 15866683
[TBL] [Abstract][Full Text] [Related]
17. Tumors after transplantation: are there associated factors?
Jacobs U; Paar D; Buszello H; Klehr HU
Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
[No Abstract] [Full Text] [Related]
18. Experience with cyclosporine.
Langone AJ; Helderman JH
Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
[No Abstract] [Full Text] [Related]
19. [Immunosuppression and treatment of graft rejection after kidney transplantation].
May G
Urologe A; 1994 Sep; 33(5):365-9. PubMed ID: 7974923
[TBL] [Abstract][Full Text] [Related]
20. Is sensitivity to cyclosporine influenced by the HLA-DR phenotype of kidney graft recipients?
Kyriakopoulos G; Antoniadis A; Gakis D; Papanikolaou V
Transplant Proc; 1996 Dec; 28(6):3294-5. PubMed ID: 8962278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
